These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1561 related items for PubMed ID: 17896605
21. Prevalence of hepatitis B and C among HIV positive patients in Georgia and its associated risk factors. Badridze N, Chkhartishvili N, Abutidze A, Gatserelia L, Sharvadze L. Georgian Med News; 2008 Dec; (165):54-60. PubMed ID: 19124918 [Abstract] [Full Text] [Related]
22. High risk of occult hepatitis B virus infection in HIV-positive patients from South Africa. Mphahlele MJ, Lukhwareni A, Burnett RJ, Moropeng LM, Ngobeni JM. J Clin Virol; 2006 Jan; 35(1):14-20. PubMed ID: 15916918 [Abstract] [Full Text] [Related]
23. Analysis of occult hepatitis B virus infection in liver tissue of HIV patients with chronic hepatitis C. Raffa G, Maimone S, Cargnel A, Santantonio T, Antonucci G, Massari M, Schiavini M, Caccamo G, Pollicino T, Raimondo G. AIDS; 2007 Oct 18; 21(16):2171-5. PubMed ID: 18090043 [Abstract] [Full Text] [Related]
24. Hepatitis C and B virus infections in hepatocellular carcinoma. Analysis of direct detection of viral genome in paraffin embedded tissues. Edamoto Y, Tani M, Kurata T, Abe K. Cancer; 1996 May 01; 77(9):1787-91. PubMed ID: 8646675 [Abstract] [Full Text] [Related]
25. Major risk of blood transfusion in hemolytic anemia patients. Omar N, Salama K, Adolf S, El-Saeed GS, Abdel Ghaffar N, Ezzat N. Blood Coagul Fibrinolysis; 2011 Jun 01; 22(4):280-4. PubMed ID: 21508832 [Abstract] [Full Text] [Related]
26. Interference of replication between hepatitis B and C viruses in patients infected with HIV. Yang RR, Gui X, Chen XY, Zhu Y. J Med Virol; 2011 Jul 01; 83(7):1159-64. PubMed ID: 21567419 [Abstract] [Full Text] [Related]
27. Occult hepatitis B virus infection in HIV-infected patients with isolated hepatitis B core antibody. Azadmanesh K, Mohraz M, Aghakhani A, Edalat R, Jam S, Eslamifar A, Banifazl M, Moradmand-Badie B, Ramezani A. Intervirology; 2008 Jul 01; 51(4):270-4. PubMed ID: 18841029 [Abstract] [Full Text] [Related]
28. Hepatitis B and C in the hemodialysis unit of Tocantins, Brazil: serological and molecular profiles. Souza KP, Luz JA, Teles SA, Carneiro MA, Oliveira LA, Gomes AS, Dias MA, Gomes SA, Yoshida CF, Martins RM. Mem Inst Oswaldo Cruz; 2003 Jul 01; 98(5):599-603. PubMed ID: 13677340 [Abstract] [Full Text] [Related]
29. Rational use of polymerase chain reaction--based detection of viral genomes in patients with serologic markers of hepatitis B or C virus infection. Pfeffel F, Oesterreicher C, Penner E, Ferenci P, Sillaber C, Fiedler R, Müller C. Wien Klin Wochenschr; 1997 Jan 17; 109(1):20-4. PubMed ID: 9037744 [Abstract] [Full Text] [Related]
30. Hepatitis B, C seroprevalence and delta viruses in HIV-1 Senegalese patients at HAART initiation (retrospective study). Diop-Ndiaye H, Touré-Kane C, Etard JF, Lô G, Diaw P, Ngom-Gueye NF, Gueye PM, Ba-Fall K, Ndiaye I, Sow PS, Delaporte E, Mboup S. J Med Virol; 2008 Aug 17; 80(8):1332-6. PubMed ID: 18551596 [Abstract] [Full Text] [Related]
31. Prevalence and significance of hepatitis C viremia in chronic active hepatitis B. Crespo J, Lozano JL, de la Cruz F, Rodrigo L, Rodríguez M, San Miguel G, Artiñano E, Pons-Romero F. Am J Gastroenterol; 1994 Aug 17; 89(8):1147-51. PubMed ID: 8053425 [Abstract] [Full Text] [Related]
32. Occult hepatitis B virus infection and lamivudine-resistant mutations in isolates from renal patients undergoing hemodialysis. Motta JS, Mello FC, Lago BV, Perez RM, Gomes SA, Figueiredo FF. J Gastroenterol Hepatol; 2010 Jan 17; 25(1):101-6. PubMed ID: 19817965 [Abstract] [Full Text] [Related]
33. High rates of active hepatitis B and C co-infections in HIV-1 infected Cameroonian adults initiating antiretroviral therapy. Laurent C, Bourgeois A, Mpoudi-Ngolé E, Kouanfack C, Ciaffi L, Nkoué N, Mougnutou R, Calmy A, Koulla-Shiro S, Ducos J, Delaporte E. HIV Med; 2010 Jan 17; 11(1):85-9. PubMed ID: 19659944 [Abstract] [Full Text] [Related]
35. Prevalence of hepatitis B virus and hepatitis C virus in patients with human immunodeficiency virus infection in Central China. Chen X, He JM, Ding LS, Zhang GQ, Zou XB, Zheng J. Arch Virol; 2013 Sep 17; 158(9):1889-94. PubMed ID: 23553454 [Abstract] [Full Text] [Related]
36. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa. Vermeulen M, Lelie N, Sykes W, Crookes R, Swanevelder J, Gaggia L, Le Roux M, Kuun E, Gulube S, Reddy R. Transfusion; 2009 Jun 17; 49(6):1115-25. PubMed ID: 19309474 [Abstract] [Full Text] [Related]
37. High prevalence of occult hepatitis B in Baltimore injection drug users. Torbenson M, Kannangai R, Astemborski J, Strathdee SA, Vlahov D, Thomas DL. Hepatology; 2004 Jan 17; 39(1):51-7. PubMed ID: 14752822 [Abstract] [Full Text] [Related]
38. HBV and HCV infection in Japanese dental care workers. Nagao Y, Matsuoka H, Kawaguchi T, Ide T, Sata M. Int J Mol Med; 2008 Jun 17; 21(6):791-9. PubMed ID: 18506374 [Abstract] [Full Text] [Related]
39. Coinfection by human immunodeficiency virus, hepatitis B virus and hepatitis C virus in injecting drug users. Devi KhS, Singh NB, Singh HL, Singh YM. J Indian Med Assoc; 2009 Mar 17; 107(3):144, 146-7. PubMed ID: 19810379 [Abstract] [Full Text] [Related]
40. Low prevalence of hepatitis B virus and hepatitis C virus co-infection in patients with human immunodeficiency virus in Northern India. Tripathi AK, Khanna M, Gupta N, Chandra M. J Assoc Physicians India; 2007 Jun 17; 55():429-31. PubMed ID: 17879496 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]